Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(30 sites)
United States
University of Arizona Cancer Center - Tucson /ID# 262698, Tucson, Arizona Yale University School of Medicine /ID# 225707, New Haven, Connecticut Johns Hopkins Hospital /ID# 254056, Baltimore, Maryland Beth Israel Deaconess Medical Center /ID# 252009, Boston, Massachusetts Dana-Farber Cancer Institute /ID# 249642, Boston, Massachusetts University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor, Michigan NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869, New York, New York Duke Cancer Center /ID# 251975, Durham, North Carolina Carolina BioOncology Institute /ID# 225704, Huntersville, North Carolina Perelman Center for Advanced Medicine /ID# 250188, Philadelphia, Pennsylvania UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh, Pennsylvania Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705, Providence, Rhode Island University of Texas Southwestern Medical Center /ID# 251974, Dallas, Texas University of Texas MD Anderson Cancer Center /ID# 252004, Houston, Texas NEXT Oncology /ID# 225708, San Antonio, Texas France
Institut Paoli-Calmettes /ID# 260956, Marseille, Bouches-du-Rhone IUCT Oncopole /ID# 252673, Toulouse, Occitanie Centre Antoine-Lacassagne /ID# 252606, Nice, Provence-Alpes-Côte d'Azur Region Hopital Foch /ID# 252607, Suresnes Israel
Rabin Medical Center /ID# 263631, Petah Tikva, Central District Hadassah Medical Center /ID# 252366, Jerusalem, Jerusalem The Chaim Sheba Medical Center /ID# 226756, Ramat Gan, Tel Aviv Japan
National Cancer Center Hospital /ID# 225884, Chuo-ku, Tokyo Wakayama Medical University Hospital /ID# 252988, Wakayama, Wakayama South Korea
Seoul National University Hospital /ID# 254635, Seoul, Seoul Teugbyeolsi Samsung Medical Center /ID# 260664, Seoul, Seoul Teugbyeolsi Yonsei University Health System Severance Hospital /ID# 260665, Seoul Spain
Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 252524, L'Hospitalet de Llobregat, Barcelona Hospital Universitario 12 de Octubre /ID# 257374, Madrid, Madrid Hospital Universitario HM Sanchinarro /ID# 228034, Madrid, Madrid